elearning

Register for free and gain unlimited access to our extensive elearning library
Earn CME points and track your learning activity with hundreds of hours of continuing medical education.
Bookmark and Share

The Tobacco Epidemic: Part One

This e-learning course is comprised of 8 modules exploring how to deliver an effective cessation programme to your patients. Over the duration of this course you will learn about how we can combat the tobacco epidemic, methods for promoting a successful quit attempt, supporting your patients through their quit plan and pharmacological and non-pharmacological treatment for tobacco dependence. The content was developed alongside experts in Tobacco Cessation from King's College London.

Module one (part one) focuses on the tobacco epidemic, including: types of tobacco use, what makes it an addictive substance and its prevalence on a global scale.

Published November 2017.

The Tobacco Epidemic: Part One
Module
English
0 CME Points

Target audience

This module is for health professionals/students looking to expand their knowledge in the field of tobacco addiction with a focus on tobacco dependence treatment.

Learning objectives

Participants will gain knowledge and understanding of:

  • What tobacco is and how it’s commonly used.
  • The global scale of the tobacco epidemic.
  • Why tobacco is one of the most powerful addictive substances and how dependence develops.

IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Disclosure policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.

Support

Production of this module was funded by an unrestricted grant from Pfizer.